Short answer · Medically reviewed summary · Last updated: 2026-04-07
Anemia is a common global health condition affecting approximately 25% of the world's population, though its prevalence varies significantly based on underlying causes such as iron deficiency, chronic disease, or genetic factors. While general anemia is widespread, many specific rare forms of the condition, such as aplastic anemia or certain hemolytic anemias, have much lower prevalence rates and remain underdiagnosed in global clinical settings. Is anemia considered a rare disease? While the umbrella term "anemia" describes a common clinical finding rather than a single rare disease, many specific subtypes are classified as rare or ultra-rare conditions.
Anemia is a common global health condition affecting approximately 25% of the world's population, though its prevalence varies significantly based on underlying causes such as iron deficiency, chronic disease, or genetic factors. While general anemia is widespread, many specific rare forms of the condition, such as aplastic anemia or certain hemolytic anemias, have much lower prevalence rates and remain underdiagnosed in global clinical settings.
While the umbrella term "anemia" describes a common clinical finding rather than a single rare disease, many specific subtypes are classified as rare or ultra-rare conditions. According to the World Health Organization (WHO), anemia affects approximately 1.62 billion people globally. However, for patients living with rare genetic variants—such as Fanconi anemia or paroxysmal nocturnal hemoglobinuria—the experience is one of managing a complex, orphan condition. At DiseaseMaps.org, 114 people with various forms of anemia have joined our community, reflecting the diverse spectrum of this condition, ranging from common nutritional deficiencies to rare, lifelong hematological disorders.
The prevalence of anemia is heavily influenced by demographic factors, with clear disparities in how it affects different populations:
Accurate epidemiological data for anemia is difficult to capture because it is often a secondary manifestation of another underlying health issue rather than a primary diagnosis. Challenges in data collection include:
Geographic prevalence of anemia is deeply tied to socio-economic factors and genetic predisposition. For instance, hereditary conditions like sickle cell disease—a major cause of hemolytic anemia—are significantly more prevalent in populations of African, Mediterranean, and Middle Eastern descent. In these regions, genetic adaptations that provide protection against malaria have historically increased the frequency of specific hemoglobinopathies. Consequently, understanding the specific type of anemia is essential for determining its true prevalence within a given ethnic or geographic group.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.